Roser Solans Laque Institutions of which they are part Main researcher Systemic Diseases Vall Hebron Institut de Recerca Email Roser Solans Laque Email Institutions of which they are part Main researcher Systemic Diseases Vall Hebron Institut de Recerca
Research lines Risk factors for ischemic events in biopsy-proven Giant Cell Arteritis (GCA). The study aims to investigate the risk factors for ischemic complications in patients with GCA, and the role that some endothelial growth factors may play in its development. This study is coordinated by Dr. Gonzalez Gay from University Hospital of Valdecilla, Santander. IP: Roser Solans Laque International Classification Criteria project for neuro-Behçet disease. We are currently enrolled in this multicentre study coordinated by Dr. Seema Kalra from University Hospital of North Staffordshire (UK). The study aims to define new diagnostic criteria for neuro-Behçet disease. A set of neurologists, rheumatologists and specialists in Internal Medicine from different countries, experts in the diagnosis and management of this disease, will try to define a new set of diagnostic criteria based on clinical expertise, and in the most new laboratory and radiology modern tests. IP: Roser Solans Laque Genetic bases of Behçet disease. We are currently enrolled in this multicentre study to investigate the possible influence of the genetic background in the disease pathogenesis, and to try to establish links between genetic variations and different clinical and biological patterns. The research is led by Prof. Javier Martín from the "Instituto López-Neyra" of Parasitology, CSIC (Granada). We contribute by sending samples from our cohort of patients along with the clinical data, and reviewing the results. It is supported by a SAS grant. IP: Roser Solans Laque Development and validation of a consensus of a systemic disease activity index for primary Sjögren’s syndrome. EULAR Sjögren’s Task Force. We are currently enrolled in this multicentre study supported by the “EULAR Sjögren’s Task Force” to elaborate and agree on a systemic disease activity index for patients with primary Sjögren’s syndrome, that will be useful in the management of the disease. This study is coordinated by Dr. Raphaele Seror from the “Service de Rheumatologie Hôpital Bicêtre”, France. IP: Roser Solans Laque Pagination First page « Previous page ‹ Page 1 Current page 2 Page 3 Next page › Last page » Projects Autoimmunitat i malaltia trombòtica IP: Miguel Vilardell Tarres Collaborators: Carmen Pilar Simeón i Aznar, Ernesto Trallero Araguas, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, Josefina Cortes Hernandez, Fernando Martínez Valle, Jesus Castro Marrero, Albert Selva O'Callaghan Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 49920 Reference: 2009 SGR 661 Duration: 01/01/2010 - 30/04/2014 Autoimmunitat i malaltia trombòtica IP: Miguel Vilardell Tarres Collaborators: Carmen Pilar Simeón i Aznar, Roser Solans Laque, Antonio San Jose Laporte, Vicenç Fonollosa Pla, José Ordi Ros, Albert Selva O'Callaghan, Maria Urquizu Padilla Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: Reference: 2005SGR 00279 Duration: 01/01/2006 - 31/12/2008 Pagination First page « Previous page ‹ Page 1 Current page 2
